Procentdelen af patienter med systemisk (fortrinsvis oral) anvendelse af kortikosteroid i undersøgelsesperioden var 17, 8% i montelukastgruppen og 10, 5% i fluticasongruppen.
The percentage of patients with systemic (mainly oral) corticosteroid use during the study period was 17.8% in the montelukast group and 10.5% in the fluticasone group.